# A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.

> **NCT06806995** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 30 (actual)

## Conditions studied

- PHA1A

## Interventions

- **DRUG:** Zidebactam-Cefepime
- **DRUG:** Metronidazole
- **DRUG:** FEP-ZID

## Key facts

- **NCT ID:** NCT06806995
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-21
- **Primary completion:** 2025-02-17
- **Final completion:** 2025-02-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06806995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06806995, "A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06806995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*